United States - English - NLM (National Library of Medicine)

edenbridge pharmaceuticals llc. - methenamine mandelate (unii: 695n30cinr) (methenamine - unii:j50oix95qv) - methenamine mandelate 500 mg - methenamine mandelate, usp is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also for infected residual urine sometimes accompanying neurologic diseases. when used as recommended, methenamine mandelate, usp is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop.  pathogens resistant to other antibacterial agents may respond to methenamine mandelate, usp because of the nonspecific effect of formaldehyde formed in an acid urine. prophylactic use rationale: urine is a good culture medium for many urinary pathogens. inoculation by a few organisms (relapse or reinfection) may lead to bacteriuria in susceptible individuals. thus, the rationale of management in recurring urinary tract infection (bacteriuria) is to change the urine from a growth-supporting to a growth-inhibiting medium. there is a growing body of

Canada - English - Health Canada

searchlight pharma inc - methenamine mandelate - tablet - 500mg - methenamine mandelate 500mg - urinary anti-infectives

Singapore - English - HSA (Health Sciences Authority)

sonax business solutions - general & plastic surgery - candela gentlemax with 1064nm or 755nm are intended for stable, long-term, or permanent hair reduction (permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regimen), treatment of vascular lesions, treatment of wrinkles, treatment of benign pigmented lesions. candela gentlemax with 1064nm is also intended for temporary increase in clear nail in patients with onychomycosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methenamine mandelate - tablet - 500mg, 1000mg - active: methenamine mandelate

Singapore - English - HSA (Health Sciences Authority)

sonax business solutions - general & plastic surgery - the candela vbeam laser systems are indicated for the following uses : general surgery - photocoagulation of benign cutaneous vascular lesions and benign cutaneous lesions. dermatology/plastic surgery - for treatment of benign cutaneous vascular lesions, such as facial and leg telangiectasia, rosacea, port wine stains, hemangiomas, angioma, spider angioma, poikiloderma of civatte, and benign cutaneous lesions, such as warts, scars, striae and psoriasis and the treatment of wrinkles. - treatment of benign epidermal pigmented lesions. - treatment of inflammatory acne vulgaris. gynecology - photocoagulation of benign cutaneous lesions and benign vascular lesions in gynecology. podiatry - treatment of benign cutaneous lesions, such as warts.

United States - English - NLM (National Library of Medicine)

method pharmaceuticals, llc - methenamine mandelate (unii: 695n30cinr) (methenamine - unii:j50oix95qv) - methenamine mandelate, usp is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also those neurologic diseases leading to an infected residual urine. when used as recommended, methenamine mandelate, usp is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop. pathogens resistant to other antibacterial agents may respond to methenamine mandelate, usp because of the nonspecific effect of formaldehyde formed in an acid urine. to reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine mandelate, usp and other antibacterial drugs, methenamine mandelate, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. prophylactic use rationale:  urine is a good culture medium for many urinary pathogens. inocul

United States - English - NLM (National Library of Medicine)

seton pharmaceuticals - methenamine mandelate (unii: 695n30cinr) (methenamine - unii:j50oix95qv) - methenamine mandelate is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also those neurologic diseases leading to an infected residual urine. when used as recommended, methenamine mandelate is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop.  pathogens resistant to other antibacterial agents may respond to methenamine mandelate because of the nonspecific effect of formaldehyde formed in an acid urine. prophylactic use rationale: urine is a good culture medium for many urinary pathogens. inoculation by a few organisms (relapse or reinfection) may lead to bacteriuria in susceptible individuals. thus, the rationale of management in recurring urinary tract infection (bacteriuria) is to change the urine from a growth-supporting to a growth-inhibiting medium. there is a growing body of evidence that lon

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - methenamine mandelate (unii: 695n30cinr) (methenamine - unii:j50oix95qv) - methenamine mandelate, usp is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also those neurologic diseases leading to an infected residual urine. when used as recommended, methenamine mandelate, usp is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop. pathogens resistant to other antibacterial agents may respond to methenamine mandelate, usp because of the nonspecific effect of formaldehyde formed in an acid urine. to reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine mandelate, usp and other antibacterial drugs, methenamine mandelate, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. prophylactic use rationale:  urine is a good culture medium for many urinary pathogens. inocul

United States - English - NLM (National Library of Medicine)

chartwell rx, llc - methenamine mandelate (unii: 695n30cinr) (methenamine - unii:j50oix95qv) - methenamine mandelate is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also those neurologic diseases leading to an infected residual urine. when used as recommended, methenamine mandelate is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop. pathogens resistant to other antibacterial agents may respond to methenamine mandelate because of the nonspecific effect of formaldehyde formed in an acid urine. prophylactic use rationale:  urine is a good culture medium for many urinary pathogens. inoculation by a few organisms (relapse or reinfection) may lead to bacteriuria in susceptible individuals. thus, the rationale of management in recurring urinary tract infection (bacteriuria) is to change the urine from a growth-supporting to a growth-inhibiting medium. there is a growing body of evidence that long-te

Singapore - English - HSA (Health Sciences Authority)

innomed pte ltd - general & plastic surgery - the candela family of q-switched alexandrite laser systems: 532 and 1064 nd:yag handpiece accessories are indicated for the following uses: 1. tattoo removal 2. treatment of vascular lesions 3. treatment of pigmented lesions 4. incision, excision, ablation, vaporization of soft tissue for general dermatology